Cargando…
Author's response to Letter to the Editor: Anticoagulant approach in COVID-19 patients with cerebral venous thrombosis.
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833942/ https://www.ncbi.nlm.nih.gov/pubmed/33020002 http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2020.105227 |
| _version_ | 1783642174979571712 |
|---|---|
| author | Klein, David E. Libman, Richard Kirsch, Claudia Arora, Rohan |
| author_facet | Klein, David E. Libman, Richard Kirsch, Claudia Arora, Rohan |
| author_sort | Klein, David E. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7833942 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78339422021-01-26 Author's response to Letter to the Editor: Anticoagulant approach in COVID-19 patients with cerebral venous thrombosis. Klein, David E. Libman, Richard Kirsch, Claudia Arora, Rohan J Stroke Cerebrovasc Dis Ltetter to the Editor Published by Elsevier Inc. 2020-12 2020-07-31 /pmc/articles/PMC7833942/ /pubmed/33020002 http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2020.105227 Text en © 2020 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Ltetter to the Editor Klein, David E. Libman, Richard Kirsch, Claudia Arora, Rohan Author's response to Letter to the Editor: Anticoagulant approach in COVID-19 patients with cerebral venous thrombosis. |
| title | Author's response to Letter to the Editor: Anticoagulant approach in COVID-19 patients with cerebral venous thrombosis. |
| title_full | Author's response to Letter to the Editor: Anticoagulant approach in COVID-19 patients with cerebral venous thrombosis. |
| title_fullStr | Author's response to Letter to the Editor: Anticoagulant approach in COVID-19 patients with cerebral venous thrombosis. |
| title_full_unstemmed | Author's response to Letter to the Editor: Anticoagulant approach in COVID-19 patients with cerebral venous thrombosis. |
| title_short | Author's response to Letter to the Editor: Anticoagulant approach in COVID-19 patients with cerebral venous thrombosis. |
| title_sort | author's response to letter to the editor: anticoagulant approach in covid-19 patients with cerebral venous thrombosis. |
| topic | Ltetter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833942/ https://www.ncbi.nlm.nih.gov/pubmed/33020002 http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2020.105227 |
| work_keys_str_mv | AT kleindavide authorsresponsetolettertotheeditoranticoagulantapproachincovid19patientswithcerebralvenousthrombosis AT libmanrichard authorsresponsetolettertotheeditoranticoagulantapproachincovid19patientswithcerebralvenousthrombosis AT kirschclaudia authorsresponsetolettertotheeditoranticoagulantapproachincovid19patientswithcerebralvenousthrombosis AT arorarohan authorsresponsetolettertotheeditoranticoagulantapproachincovid19patientswithcerebralvenousthrombosis |